Cancer latest info, news, treatment, advice- Mainstream and alternative cancer cures

ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (IMUC), a biotechnology company, announced the filing of a provisional U.S. patent application relating to its novel vaccine technology targeting cancer stem cells. The vaccine technology is exclusively licensed from Cedars-Sinai Medical Center. The patent claims are broad and include compositions of peptides for cancer immunotherapy as well as methods for inducing immune responses against tumor antigens in cancer patients.

lCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced today the completion of enrollment as per protocol in the Phase 2 clinical trial of sapacitabine, the Company's oral nucleoside analogue, in elderly patients with acute myeloid leukemia (AML). Interim results from this trial are expected to be available by the end of 2008 and final results during the second half of 2009.

Investigators from the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic effects of chemotherapy in children and adults. Their findings may one day help in the development of targeted therapies for leukemia, multiple myeloma and other cancers of the blood. The researchers, led by Kristin T. Chun, Ph.D.

Toxins in food often have a bad, bitter taste that makes people want to spit them out. New UC Irvine research finds that bitterness also slows the digestive process, keeping bad food in the stomach longer and increasing the chances that it will be expelled. This second line of defense in the gut against dietary toxins also triggers the production of a hormone that makes people feel full, presumably to keep them from eating more of the toxic food.

VASCULAR BIOLOGY: A real-time view of blood flow through the pancreas A team of researchers at Vanderbilt University, Nashville, has developed a new microscopy approach that enabled them to image, in real time, the flow of blood in mouse pancreatic islets of Langerhans. The pancreatic islets of Langerhans have a central role in regulating the amount of glucose in the blood.

Medical and life scientists will be able to share information collected from many thousands of cases thanks to a digital network aunched at The Australian National University in Canberra The ANU node of BioGrid was launched at the John Curtin School of Medical Research, Garran Road, ANU by Senator Kate Lundy. The ACT node of the BioGrid network is a collaborative venture between ANU and BioGrid Australia.

Deerfield Urethane, Inc. (Deerfield), a wholly owned subsidiary of Bayer MaterialScience LLC (BMS) and one of the leading suppliers of custom, made-to-order thermoplastic polyurethane (TPU) and specialty elastomer film and sheet, is proud to announce its collaboration with BHS International (BHS), a breast health company co-founded by Olivia Newton-John, in the development and production of the Liv® Aid breast self-exam aid.

Medical research is a cornerstone of Frontiers in Optics 2008 (FiO), the 92nd Annual Meeting of the Optical Society (OSA), being held Oct. 19-23 at the Riverside Convention Center in Rochester, N.Y. FiO 2008 will take place alongside Laser Science XXIV, the annual meeting of the American Physical Society's Division of Laser Science. MEDICAL RESEARCH HIGHLIGHTS AT FiO Following are a few of the many technical highlights to be discussed at the meeting.

Roswell Park Cancer Institute (RPCI) will bring together national cancer experts from around the United States to discuss "The Future of Cancer Research: Science and Patient Impact" during a Centennial Symposium sponsored by the American Association for Cancer Research (AACR), October 27-28, Research Studies Center, RPCI.

Yale University researchers have described a molecular traffic signal in the middle of a busy biological highway that influences such diverse processes as the production of insulin, activation of the immune system, creation of new brain cells and formation of tumors. The centrality of this traffic signal, known as mTOR, makes it of intense interest to researchers searching for new treatments for a wide variety of diseases, said Michael Simons, M.D.

Alfacell Corporation (Nasdaq: ACEL) announced that a paper published in Cell Cycle (2008; Vol. 7, Issue 20) reports that ONCONASE (ranpirnase) targets small interfering RNA (siRNA), likely within the RNA-induced silencing complex (RISC) of the RNA interference (RNAi) mechanism.

The Melanoma Foundation of New England and the Boston University School of Medicine are co-sponsoring an Accreditation Council for Continuing Medical Education (ACCME) course to update non-dermatologists on the detection and management of melanoma.

Texas Children's Cancer Center today launched Passport for Care, an innovative Web-based application that provides childhood cancer survivors and their physicians with immediate access to a survivor's diagnosis and treatment history. Passport for Care provides detailed, individualized health care recommendations based on the most up-to-date national survivorship care guidelines. Passport for Care inventor and Texas Children's Cancer Center director Dr.

The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy, and support for myeloma patients, families, researchers, and physicians - today congratulated French researcher Dr. Luc Montagnier as co-recipient of the 2008 Nobel Prize in medicine. Dr.

As more individuals with cancer are being treated as outpatients, the University of Rochester Medical Center is working on an emerging problem: how to prevent the life-threatening blood clots that can accompany some newer cancer drugs. A team of researchers, awarded $3 million this month by the National Heart, Lung and Blood Institute, is seeking to change the current standard of care by conducting a landmark clinical trial.

Today, experts at the American Institute for Cancer Research (AICR) welcomed a new set of guidelines on physical activity from the U.S. Department of Health and Human Services. Included in the 2008 Physical Activity Guidelines for Americans is specific acknowledgment that regular activity lowers risk for colon, breast and other cancers.

The American College of Obstetricians and Gynecologists (ACOG) has joined forces with the nation's leading cancer advocacy groups in a landmark television event and education initiative, Frosted Pink with a Twist, dedicated to raising awareness of cancers primarily affecting women. Today, one in three women in the US will develop cancer in her lifetime.

Exposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists. The research study, led by UC's Nira Ben-Jonathan, PhD, says that BPA - a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans - actually induces a group of proteins that protect cancer cells from the toxic effects of chemotherapy.

The Indiana University Melvin and Bren Simon Cancer Center has been recognized as a premier cancer center for the third consecutive time by the National Cancer Institute. Since 1999, the IU Simon Cancer Center has carried the prestigious NCI designation. This year, the NCI awarded the IU Simon Cancer Center a five-year, $6.5 million support grant following a multi-step competitive process.

Cancer immune surveillance is considered to be important in the anti-tumor protection of the host. The growing tumor escapes the immune control under the immunosuppressive conditions. The surgical removal of the tumor may reverse the immunosuppression. The TF antigen and Tn belong to tumor-associated carbohydrate antigens (TACA). TF antigen is implicated in the metastatic spread due to the adhesion of cancer cells to the endothelium.